What are the ideal clinical profiles for and distinctions among the fixed ratio, combination formulations? What are their potential advantages and unique therapeutic windows of opportunities?

What are the ideal clinical profiles for and distinctions among the fixed ratio, combination formulations? What are their potential advantages and unique therapeutic windows of opportunities?

What are the ideal clinical profiles for and distinctions among the fixed ratio, combination formulations? What are their potential advantages—i.e., reduced risk of weight gain and hypoglycemia —and unique therapeutic windows of opportunities?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Stefano Del Prato, MD PhD

Stefano Del Prato, MD PhD

Professor of Endocrinology and Metabolism
School of Medicine, University of Pisa
Chief of the Section of Diabetes
University of Pisa, Italy
Clinical Associate Professor of Medicine
University of Texas, San Antonio Health Science Center
San Antonio, Texas